Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WEST PHARMACEUTICAL SERVICES, INC.

(WST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

West Pharmaceutical: Q2 Earnings Snapshot

07/29/2021 | 06:36am EDT

EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported second-quarter profit of $187.3 million.

The Exton, Pennsylvania-based company said it had net income of $2.47 per share. Earnings, adjusted for non-recurring gains, came to $2.46 per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.74 per share.

The medical device company posted revenue of $723.6 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $665.6 million.

West Pharmaceutical expects full-year earnings in the range of $8.05 to $8.20 per share, with revenue in the range of $2.76 billion to $2.79 billion.

West Pharmaceutical shares have risen 36% since the beginning of the year. The stock has climbed 45% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about WEST PHARMACEUTICAL SERVICES, INC.
10/19WEST PHARMACEUTICAL SERVICES : Introduces DeltaCube™ Modeling Platform and NovaGuard..
PR
10/19West Pharmaceutical Services, Inc. Introduces DeltaCube™ Modeling Platform and NovaGuar..
CI
10/14WEST PHARMACEUTICAL SERVICES : to Host Third-Quarter 2021 Conference Call
PR
08/24WEST PHARMACEUTICAL SERVICES : Change in Directors or Principal Officers, Regulation FD Di..
AQ
08/23WEST PHARMACEUTICAL SERVICES INC : Change in Directors or Principal Officers, Regulation F..
AQ
08/23WEST PHARMACEUTICAL SERVICES : Elects New Director to the Board (Form 8-K)
PU
08/23WEST PHARMACEUTICAL SERVICES : Elects New Director to the Board
PR
08/23West Pharmaceutical Services, Inc. Elects Molly Joseph as Its Newest Member to the Boa..
CI
08/03Pharmaceutics International, Inc. to Platform West Pharmaceutical Services, Inc.’s Daik..
CI
07/30WEST PHARMACEUTICAL SERVICES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
More news
Analyst Recommendations on WEST PHARMACEUTICAL SERVICES, INC.
More recommendations
Financials (USD)
Sales 2021 2 799 M - -
Net income 2021 633 M - -
Net cash 2021 656 M - -
P/E ratio 2021 50,1x
Yield 2021 0,16%
Capitalization 31 159 M 31 159 M -
EV / Sales 2021 10,9x
EV / Sales 2022 9,96x
Nbr of Employees 9 200
Free-Float 97,6%
Chart WEST PHARMACEUTICAL SERVICES, INC.
Duration : Period :
West Pharmaceutical Services, Inc. Technical Analysis Chart | WST | US9553061055 | MarketScreener
Technical analysis trends WEST PHARMACEUTICAL SERVICES, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 421,19 $
Average target price 402,50 $
Spread / Average Target -4,44%
EPS Revisions
Managers and Directors
Eric Mark Green President, Chief Executive Officer & Director
Bernard J. Birkett Chief Financial Officer, Treasurer & Senior VP
Patrick J. Zenner Non-Executive Chairman
Silji Abraham Chief Technology Officer & Senior Vice President
David A. Montecalvo SVP, Chief Operations & Supply Chain Officer
Sector and Competitors
1st jan.Capi. (M$)
WEST PHARMACEUTICAL SERVICES, INC.46.34%31 236
ABBOTT LABORATORIES14.21%221 691
MEDTRONIC PLC3.85%163 718
BECTON, DICKINSON AND COMPANY-1.50%70 784
HOYA CORPORATION21.65%55 133
DEXCOM, INC.53.24%54 963